Table 4.

Alemtuzumab treatment trials in T-PLL

Alemtuzumab treatment trials in T-PLL

MPFS indicates median progression-free survival; and MS, median overall survival.

*Retrospective analysis of compassionate-use trial.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal